• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAdial Pharmaceuticals
    Picture of Adial Pharmaceuticals logo

    ADIL — Adial Pharmaceuticals News Story

    $3.920.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    • Market Cap
      $10.29m
    • Enterprise Value
      -$18.42m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ADIL Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ADIL Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:43 PM

    Picture of Adial Pharmaceuticals logoAdial Pharmaceuticals
    11/06/2026 17:43
    NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 12:43 PM

    Recent news on Adial Pharmaceuticals

    See all news
    • Brief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics

      Wed 20:27
    • Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer

      Mon 12:09
    • Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

      30/09/2026 23:40
    • Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing

      28/08/2026 21:52
    • Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

      25/08/2026 21:07

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.